ANDA 61452, held by Apothecon. Cloxacillin Sodium.
As of Nov 16, 2026, ANDA 61452 (Cloxacillin Sodium), held by Apothecon, was first approved by FDA on Apr 1, 1971, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 1, 1971 | Original application | Approved | None posted |
| Cloxacillin SodiumEQ 250MG BASE · capsule;oral | Cloxacillin Sodium | Discontinued |
| Cloxacillin SodiumEQ 500MG BASE · capsule;oral | Cloxacillin Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters